Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-01-06 @ 4:44 AM
Study NCT ID:
NCT02429258
Status:
COMPLETED
Last Update Posted:
2017-06-14
First Post:
2015-04-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05
Start Date Type:
None
Primary Completion Date:
2015-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-10
Completion Date Type:
ACTUAL
First Submit Date:
2015-04-08
First Submit QC Date:
None
Study First Post Date:
2015-04-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-10-07
Results First Submit QC Date:
None
Results First Post Date:
2017-04-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-18
Last Update Post Date:
2017-06-14
Last Update Post Date Type:
ACTUAL